Substance
ID:1825575
Names and Identifiers
IUPAC name
(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-2-(3-{[5-({3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl]propanoyl}oxy)pentyl]oxy}-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium dibenzenesulfonate
IUPAC Traditional name
cisatracurium besylate
Synonyms
cisatracurium besylate(1R,2R,1'R,2'R)-atracurium besylate(1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate(1R-cis,1'R-cis)-atracurium besylatecisatracurium besilatecisatracurium dibenzenesulfonate
Registration numbers
PubChem CID
CAS Number
DrugBank ID
ACToR Database
CHEMBL
CompTox Database
SureChEMBL Database
Patent number
KEGG DRUG Database
CHEBI ID
PubChem SID
Properties
No Data Available
Click here to submit data
Molecule Details
The (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate. Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for endotracheal intubation, to aid controlled ventilation, and in general anaesthesia.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data